02.03.2015 • News

Bachem acquires American Peptide Company

Bachem announced today the forthcoming acquisition of American Peptide Company (APC), based in California. The Japanese seller ILS, a wholly-owned subsidiary of Otsuka Chemical, and the buyer, Bachem Americas have signed a contract to transfer all shares of APC. Both parties have agreed not to disclose the terms of the deal.

Company

Logo:

Bachem

Hauptstr. 144
4416 Bubendorf
Switzerland

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read